300453 三鑫医疗
已收盘 12-31 15:00:00
资讯
新帖
简况
三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证，12月29日股价下跌2.26%
证券之星 · 12-29 22:19
三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证，12月29日股价下跌2.26%
三鑫医疗（300453）披露补选第五届董事会独立董事议案获股东会通过，12月26日股价下跌0.45%
证券之星 · 2025-12-26
三鑫医疗（300453）披露补选第五届董事会独立董事议案获股东会通过，12月26日股价下跌0.45%
股市必读：三鑫医疗（300453）11月4日董秘有最新回复
证券之星 · 2025-11-05
股市必读：三鑫医疗（300453）11月4日董秘有最新回复
图解三鑫医疗三季报：第三季度单季净利润同比增长13.29%
证券之星 · 2025-10-29
图解三鑫医疗三季报：第三季度单季净利润同比增长13.29%
三鑫医疗（300453）披露向不特定对象发行可转换公司债券申请获深交所受理，10月29日股价下跌1.4%
证券之星 · 2025-10-29
三鑫医疗（300453）披露向不特定对象发行可转换公司债券申请获深交所受理，10月29日股价下跌1.4%
三鑫医疗（300453）披露2024年限制性股票激励计划部分限制性股票回购注销完成，10月28日股价上涨1.75%
证券之星 · 2025-10-28
三鑫医疗（300453）披露2024年限制性股票激励计划部分限制性股票回购注销完成，10月28日股价上涨1.75%
三鑫医疗：坚持聚焦主业创新驱动
证券之星 · 2025-09-16
三鑫医疗：坚持聚焦主业创新驱动
三鑫医疗（300453）384.96万股限售股将于9月1日解禁，占总股本0.74%
证券之星 · 2025-09-01
三鑫医疗（300453）384.96万股限售股将于9月1日解禁，占总股本0.74%
三鑫医疗：公司部分股东减持系根据其自身资金安排作出的投资决策计划
证券之星 · 2025-08-29
三鑫医疗：公司部分股东减持系根据其自身资金安排作出的投资决策计划
三鑫医疗股价下跌3.17% 公司回购方案获股东大会通过
金融界 · 2025-08-28
三鑫医疗股价下跌3.17% 公司回购方案获股东大会通过
三鑫医疗最新公告：获得血液透析浓缩液医疗器械注册证
证券之星 · 2025-08-26
三鑫医疗最新公告：获得血液透析浓缩液医疗器械注册证
股市必读：三鑫医疗（300453）8月22日披露最新机构调研信息
证券之星 · 2025-08-25
股市必读：三鑫医疗（300453）8月22日披露最新机构调研信息
【机构调研记录】宏利基金调研三鑫医疗、芯动联科等4只个股（附名单）
证券之星 · 2025-08-25
【机构调研记录】宏利基金调研三鑫医疗、芯动联科等4只个股（附名单）
三鑫医疗股价下跌2.01% 四款产品获欧盟MDR认证
金融界 · 2025-08-21
三鑫医疗股价下跌2.01% 四款产品获欧盟MDR认证
三鑫医疗最新公告：公司产品获得欧盟MDR认证
证券之星 · 2025-08-21
三鑫医疗最新公告：公司产品获得欧盟MDR认证
三鑫医疗股价下跌5.42% 盘中一度快速反弹2%
金融界 · 2025-08-20
三鑫医疗股价下跌5.42% 盘中一度快速反弹2%
8月19日增减持汇总：暂无增持 三鑫医疗等12股减持（表）
新浪证券 · 2025-08-19
8月19日增减持汇总：暂无增持 三鑫医疗等12股减持（表）
三鑫医疗最新公告：多名股东计划减持股份
证券之星 · 2025-08-19
三鑫医疗最新公告：多名股东计划减持股份
三鑫医疗涨10.89%，华安证券六日前给出“买入”评级
证券之星 · 2025-08-18
三鑫医疗涨10.89%，华安证券六日前给出“买入”评级
【机构调研记录】朱雀基金调研三鑫医疗、帝尔激光
证券之星 · 2025-08-14
【机构调研记录】朱雀基金调研三鑫医疗、帝尔激光
加载更多
公司概况
公司名称：
江西三鑫医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2015-05-15
主营业务：
江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液净化类、给药器具类、心胸外科类、其他类。公司荣获“国家工信部智能制造优秀场景”“江西省智能制造标杆企业”“江西省先进级智能工厂”“5G+工业互联网”应用示范项目等荣誉，在智能制造和数字化转型领域获权威认可。
发行价格：
12.87
{"stockData":{"symbol":"300453","market":"SZ","secType":"STK","nameCN":"三鑫医疗","latestPrice":8.72,"timestamp":1767164595000,"preClose":8.66,"halted":0,"volume":3618632,"delay":0,"changeRate":0.0069,"floatShares":360000000,"shares":522000000,"eps":0.4683,"marketStatus":"已收盘","change":0.06,"latestTime":"12-31 15:00:00","open":8.67,"high":8.76,"low":8.61,"amount":31408700,"amplitude":0.0173,"askPrice":8.73,"askSize":355,"bidPrice":8.72,"bidSize":80,"shortable":0,"etf":0,"ttmEps":0.4683,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767576600000},"marketStatusCode":5,"adr":0,"adjPreClose":8.66,"symbolType":"stock","openAndCloseTimeList":[[1767144600000,1767151800000],[1767157200000,1767164400000]],"highLimit":9.53,"lowLimit":7.79,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":522084275,"isCdr":false,"pbRate":3.27,"roa":"--","peRate":18.620542,"roe":"13.5%","epsLYR":0.4416,"committee":-0.215416,"marketValue":4553000000,"turnoverRate":0.0101,"status":0,"floatMarketCap":3138000000},"requestUrl":"/m/hq/s/300453","defaultTab":"news","newsList":[{"id":"2595629735","title":"三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证，12月29日股价下跌2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595629735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595629735?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:19","pubTimestamp":1767017956,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，三鑫医疗报收于8.66元，较前一交易日下跌2.26%，最新总市值为45.21亿元。该股当日开盘8.85元，最高8.91元，最低8.63元，成交额达6940.66万元，换手率为2.21%。公司近日发布公告称，其控股子公司成都威力生生物科技有限公司因生产经营需要，已对其《医疗器械生产许可证》的生产地址进行变更，并完成相关登记手续。公告指出，此次变更不涉及实质性生产经营变化，不会对公司生产经营产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900037735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1583","09997","BK1222","BK0251","300453","BK1100","159883","09996"],"gpt_icon":0},{"id":"2594283294","title":"三鑫医疗（300453）披露补选第五届董事会独立董事议案获股东会通过，12月26日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594283294","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594283294?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:40","pubTimestamp":1766760027,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，三鑫医疗报收于8.86元，较前一交易日下跌0.45%，最新总市值为46.26亿元。近日，江西三鑫医疗科技股份有限公司发布2025年第二次临时股东会决议公告，宣布会议于2025年12月26日召开，审议通过《关于补选第五届董事会独立董事的议案》。出席会议的股东共126人，代表股份170,377,987股，占公司有表决权股份总数的32.6442%。议案获得同意票占出席股东会有效表决权股份总数的96.8261%，反对占3.1619%，弃权占0.0120%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600036714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"gpt_icon":0},{"id":"2581757176","title":"股市必读：三鑫医疗（300453）11月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2581757176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581757176?lang=zh_cn&edition=full","pubTime":"2025-11-05 02:08","pubTimestamp":1762279698,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，三鑫医疗报收于9.83元，上涨1.34%，换手率3.79%，成交量13.63万手，成交额1.32亿元。董秘最新回复投资者： 请问董秘，大股东减持情况进行到哪步了？当日关注点来自交易信息汇总：11月4日主力资金净流入1348.05万元，显示主力对个股呈积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500001169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"gpt_icon":0},{"id":"2579297057","title":"图解三鑫医疗三季报：第三季度单季净利润同比增长13.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579297057","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579297057?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:34","pubTimestamp":1761737669,"startTime":"0","endTime":"0","summary":"证券之星消息，三鑫医疗2025年三季报显示，前三季度公司主营收入11.68亿元，同比上升7.88%；归母净利润1.85亿元，同比上升10.16%；扣非净利润1.67亿元，同比上升10.09%；其中2025年第三季度，公司单季度主营收入4.07亿元，同比上升2.76%；单季度归母净利润6986.1万元，同比上升13.29%；单季度扣非净利润6373.56万元，同比上升11.47%；负债率36.12%，投资收益351.4万元，财务费用37.01万元，毛利率35.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900040371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453"],"gpt_icon":0},{"id":"2579760079","title":"三鑫医疗（300453）披露向不特定对象发行可转换公司债券申请获深交所受理，10月29日股价下跌1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579760079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579760079?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:27","pubTimestamp":1761733633,"startTime":"0","endTime":"0","summary":"同日，三鑫医疗发布公告称，公司于近日收到深圳证券交易所出具的《关于受理江西三鑫医疗科技股份有限公司向不特定对象发行可转换公司债券申请文件的通知》，深交所对公司报送的向不特定对象发行可转换公司债券申请文件进行了核对，认为申请文件齐备，决定予以受理。本次发行可转换公司债券事项尚需通过深交所审核，并获得中国证券监督管理委员会同意注册的决定后方可实施，能否通过审核、注册及最终通过时间存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"gpt_icon":0},{"id":"2578931488","title":"三鑫医疗（300453）披露2024年限制性股票激励计划部分限制性股票回购注销完成，10月28日股价上涨1.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578931488","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578931488?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:53","pubTimestamp":1761645217,"startTime":"0","endTime":"0","summary":"截至2025年10月28日收盘，三鑫医疗报收于9.29元，较前一交易日上涨1.75%，最新总市值为48.5亿元。公司近日发布公告称，已完成2024年限制性股票激励计划中部分限制性股票的回购注销。本次回购注销的限制性股票数量为313,250股，占回购前总股本的0.06%，涉及激励对象31人，回购价格为3.1元/股加上银行同期存款利息，回购资金总额为985,277.05元，全部来源于公司自有资金。截至公告披露日，相关股份已完成注销手续，公司总股本由522,397,525股减少至522,084,275股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800033365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2567994100","title":"三鑫医疗：坚持聚焦主业创新驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2567994100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567994100?lang=zh_cn&edition=full","pubTime":"2025-09-16 20:52","pubTimestamp":1758027127,"startTime":"0","endTime":"0","summary":"证券之星消息，三鑫医疗09月16日在投资者关系平台上答复投资者关心的问题。谢谢三鑫医疗回复：尊敬的投资者，您好！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600035854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"gpt_icon":0},{"id":"2564863413","title":"三鑫医疗（300453）384.96万股限售股将于9月1日解禁，占总股本0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564863413","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564863413?lang=zh_cn&edition=full","pubTime":"2025-09-01 08:03","pubTimestamp":1756684989,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，三鑫医疗于9月1日将有384.96万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.74%。本次解禁后，公司还有1.61亿股限售股份，占总股本30.88%。三鑫医疗主营业务：医疗器械研发、制造、销售和服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100001331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"gpt_icon":0},{"id":"2563259690","title":"三鑫医疗：公司部分股东减持系根据其自身资金安排作出的投资决策计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2563259690","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563259690?lang=zh_cn&edition=full","pubTime":"2025-08-29 20:52","pubTimestamp":1756471929,"startTime":"0","endTime":"0","summary":"证券之星消息，三鑫医疗(300453)08月28日在投资者关系平台上答复投资者关心的问题。投资者提问：这几年公司的股价每次稍微有一点起色就会有股东集体减持，请问下是公司刻意的压制股价行为？或者说还是配合主力出货行为？三鑫医疗回复：尊敬的投资者，您好！公司部分股东减持系根据其自身资金安排作出的投资决策计划，本次减持计划符合法律法规及规范性文件的规定并履行了信息披露义务。公司股价波动受到宏观经济、行业政策、市场行情等多方因素的影响，请您注意投资风险，谨慎决策。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900042999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"gpt_icon":0},{"id":"2562726577","title":"三鑫医疗股价下跌3.17% 公司回购方案获股东大会通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2562726577","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562726577?lang=zh_cn&edition=full","pubTime":"2025-08-28 00:30","pubTimestamp":1756312256,"startTime":"0","endTime":"0","summary":"三鑫医疗8月27日股价报收9.78元，较前一交易日下跌0.32元，跌幅3.17%。当日开盘价为10.08元，最高触及10.17元，最低下探至9.68元，成交量为21.24万手，成交金额达2.11亿元。公司产品主要用于急慢性肾功能衰竭患者的血液透析治疗。消息面上，三鑫医疗股票回购方案已获股东大会通过，拟回购金额不超过100.24万元。该回购计划显示出公司对自身发展的信心。资金流向数据显示，8月27日三鑫医疗主力资金净流出3776.74万元，占流通市值的1.08%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/28003052758386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2562368567","title":"三鑫医疗最新公告：获得血液透析浓缩液医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2562368567","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562368567?lang=zh_cn&edition=full","pubTime":"2025-08-26 20:10","pubTimestamp":1756210201,"startTime":"0","endTime":"0","summary":"三鑫医疗(300453.SZ)公告称，公司近日获得国家药品监督管理局颁发的《医疗器械注册证》，产品为枸橼酸型血液透析浓缩液，该产品由A液和B液组成，能有效防止血栓形成，提高透析治疗的安全性。至此，公司已拥有多种特殊配方和不同型号的血液透析浓缩物，有利于提高公司产品的综合竞争力。该产品的实际销售情况取决于未来市场推广效果，公司目前尚无法预测其对未来业绩的具体影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600043722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK1583","159883","BK1574","BK0251","BK1100","09997","BK1222","09996"],"gpt_icon":0},{"id":"2562295724","title":"股市必读：三鑫医疗（300453）8月22日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2562295724","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562295724?lang=zh_cn&edition=full","pubTime":"2025-08-25 09:22","pubTimestamp":1756084923,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，三鑫医疗报收于10.26元，上涨0.1%，换手率6.52%，成交量23.3万手，成交额2.38亿元。公司公告汇总：公司四项产品获得欧盟MDR认证，有助于提高公司产品的全球市场竞争力，证书有效期至2029年12月12日。2025年上半年，公司海外市场实现营业收入1.87亿元，同比增长67.30%，其中血液透析产品出口销售收入1.65亿元，占出口总收入的88%，同比增长83.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500002910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"gpt_icon":0},{"id":"2562926298","title":"【机构调研记录】宏利基金调研三鑫医疗、芯动联科等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2562926298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562926298?lang=zh_cn&edition=full","pubTime":"2025-08-25 08:03","pubTimestamp":1756080183,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月22日披露的机构调研信息，宏利基金近期对4家上市公司进行了调研，相关名单如下：1）三鑫医疗 调研纪要：三鑫医疗表示，2025年上半年海外市场开拓成效显著，海外业务实现营业收入1.87亿元，同比增长67.30%，血液净化产品出口销售收入1.65亿元，占出口总收入的比重达88%，同比增长83.84%。2）芯动联科 调研纪要：芯动联科2025年上半年实现营收25,313.41万元，同比增长84.34%，净利润增长173.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500001725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688582","BK0214","300453","BK0251"],"gpt_icon":0},{"id":"2561992994","title":"三鑫医疗股价下跌2.01% 四款产品获欧盟MDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2561992994","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561992994?lang=zh_cn&edition=full","pubTime":"2025-08-21 22:39","pubTimestamp":1755787159,"startTime":"0","endTime":"0","summary":"三鑫医疗8月21日报收10.25元，较前一交易日下跌0.21元，跌幅2.01%。当日成交量为219152手，成交金额达2.26亿元。消息面上，三鑫医疗公告称公司四项产品获得欧盟MDR认证，包括一次性使用无菌注射针、一次性使用回缩自毁式无菌注射器带针等。该认证有效期至2029年12月12日。此外，公司公告显示多名股东计划在未来三个月内减持公司股份。资金流向方面，三鑫医疗8月21日主力资金净流出3041.99万元，近五日主力资金累计净流出8697.14万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/21223952597838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2561270469","title":"三鑫医疗最新公告：公司产品获得欧盟MDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2561270469","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561270469?lang=zh_cn&edition=full","pubTime":"2025-08-21 18:50","pubTimestamp":1755773452,"startTime":"0","endTime":"0","summary":"三鑫医疗(300453.SZ)公告称，公司于近日收到德国莱茵TÜV集团换发的欧盟医疗器械法规MDR认证证书，四项产品获得认证，包括一次性使用无菌注射针、一次性使用回缩自毁式无菌注射器带针等。公司已获得欧盟MDR认证的产品还包括一次性使用血液透析管路和一次性使用机用采血器。此次认证表明公司已建立符合欧盟MDR法规要求的质量管理体系，产品符合欧盟最新医疗器械法规要求，具备欧盟市场的最新准入条件，将对公司产品在欧盟国家及其他认可欧盟MDR认证国家的推广和销售产生积极促进作用。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100034007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","FESXmain","FSXEmain","BK0251"],"gpt_icon":0},{"id":"2560109701","title":"三鑫医疗股价下跌5.42% 盘中一度快速反弹2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560109701","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560109701?lang=zh_cn&edition=full","pubTime":"2025-08-20 21:25","pubTimestamp":1755696349,"startTime":"0","endTime":"0","summary":"三鑫医疗8月20日股价报收10.46元，较前一交易日下跌0.60元，跌幅5.42%。当日开盘价为10.62元，最高触及10.88元，最低下探10.31元，成交量为37.21万手，成交金额达3.92亿元。公司产品主要用于肾病治疗、血液透析等医疗场景。8月20日早盘9点37分，三鑫医疗股价在5分钟内快速反弹超过2%，报价10.67元，期间成交金额达8842万元。近五个交易日累计净流出6556.40万元，占流通市值的1.75%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/20212552575072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2560905801","title":"8月19日增减持汇总：暂无增持 三鑫医疗等12股减持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2560905801","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560905801?lang=zh_cn&edition=full","pubTime":"2025-08-19 22:26","pubTimestamp":1755613560,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，8月19日，盘后暂无A股上市公司披露增持情况。包括三鑫医疗、南京港、弘业期货、中航光电、和元生物、新致软件、泸天化、德美化工、富信科技、华正新材、珍宝岛、禾丰股份在内的12家A股上市公司披露减持情况。\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-08-19/doc-infmpuqv2393347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300453","BK0251"],"gpt_icon":0},{"id":"2560194502","title":"三鑫医疗最新公告：多名股东计划减持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2560194502","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560194502?lang=zh_cn&edition=full","pubTime":"2025-08-19 21:00","pubTimestamp":1755608445,"startTime":"0","endTime":"0","summary":"三鑫医疗公告称，公司控股股东、实际控制人之一致行动人彭九莲、董事毛志平、董事乐珍荣、董事刘明、副总裁王甘英、副总裁冷玲丽、副总裁刘炳荣计划在未来三个月内以集中竞价或大宗交易方式减持公司股份，减持原因为个人资金需求。其中彭九莲拟减持不超过230万股，毛志平拟减持不超过74.34万股，乐珍荣拟减持不超过39.35万股，刘明拟减持不超过16.73万股，王甘英拟减持不超过22.78万股，冷玲丽拟减持不超过13.1万股，刘炳荣拟减持不超过13.07万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081900038467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"gpt_icon":0},{"id":"2560737977","title":"三鑫医疗涨10.89%，华安证券六日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2560737977","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560737977?lang=zh_cn&edition=full","pubTime":"2025-08-18 16:28","pubTimestamp":1755505711,"startTime":"0","endTime":"0","summary":"今日三鑫医疗涨10.89%，收盘报11.1元。2025年8月12日，华安证券研究员谭国超,李婵发布了对三鑫医疗的研报《2025H1盈利能力稳定，海外市场持续高增长》，该研报对三鑫医疗给出“买入”评级。考虑到血透行业尤其是透析机和透析器还存在较大的进口替代空间，行业增长稳健，公司海外市场拓展顺利，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国元证券的马云涛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081800021722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","300453"],"gpt_icon":0},{"id":"2559741987","title":"【机构调研记录】朱雀基金调研三鑫医疗、帝尔激光","url":"https://stock-news.laohu8.com/highlight/detail?id=2559741987","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559741987?lang=zh_cn&edition=full","pubTime":"2025-08-14 08:04","pubTimestamp":1755129877,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月13日披露的机构调研信息，朱雀基金近期对2家上市公司进行了调研，相关名单如下：1）三鑫医疗 调研纪要：三鑫医疗在血液透析领域取得了显著进展。公司发行可转换公司债券募集资金不超过5.3亿元，用于血液透析相关项目及补充流动资金。国内血液透析患者数量增长迅速，透析治疗率仍有较大提升空间。旗下最近一年表现最佳的公募基金产品为朱雀企业优胜A，最新单位净值为1.49，近一年增长46.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400005379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300776","300453"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767270442916,"stockEarnings":[{"period":"1week","weight":-0.0354},{"period":"1month","weight":-0.0593},{"period":"3month","weight":-0.0449},{"period":"6month","weight":0.069},{"period":"1year","weight":0.2104},{"period":"ytd","weight":0.2104}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.014},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.143},{"period":"1year","weight":0.1841},{"period":"ytd","weight":0.1841}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江西三鑫医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"23101人(较上一季度增加26.57%)","perCapita":"15577股","listingDate":"2015-05-15","address":"江西省南昌市南昌县小蓝经济开发区富山大道999号","registeredCapital":"52208万元","survey":" 江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液净化类、给药器具类、心胸外科类、其他类。公司荣获“国家工信部智能制造优秀场景”“江西省智能制造标杆企业”“江西省先进级智能工厂”“5G+工业互联网”应用示范项目等荣誉，在智能制造和数字化转型领域获权威认可。","listedPrice":12.87},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三鑫医疗,300453,三鑫医疗股票,三鑫医疗股票老虎,三鑫医疗股票老虎国际,三鑫医疗行情,三鑫医疗股票行情,三鑫医疗股价,三鑫医疗股市,三鑫医疗股票价格,三鑫医疗股票交易,三鑫医疗股票购买,三鑫医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}